News & Updates
Filter by Specialty:

Gout, hyperuricaemia meds less common among diabetics on SGLT2is
Patients with type 2 diabetes mellitus (T2DM) taking sodium-glucose cotransporter 2 inhibitors (SGLT2is) are less likely to be prescribed antigout or antihyperuricaemic drugs, a recent study has found.
Gout, hyperuricaemia meds less common among diabetics on SGLT2is
28 Aug 2022
FMT plus anti-inflammatory diet induces, preserves remission in UC
Patients with mild-to-moderate ulcerative colitis (UC) can achieve deep remission with multidonor faecal microbiota transplantation (FMT) and anti-inflammatory diet, according to an open-label trial. Furthermore, remission can be sustained with anti-inflammatory diet over 1 year.
FMT plus anti-inflammatory diet induces, preserves remission in UC
28 Aug 2022
Dulaglutide safely controls glucose in T2D with CKD
In patients with type 2 diabetes (T2D) with chronic kidney disease (CKD), once-weekly dosage with dulaglutide achieves adequate glycaemic control along with a reduced decline in estimated glomerular filtration rate (eGFR), reports a recent study.
Dulaglutide safely controls glucose in T2D with CKD
28 Aug 2022
Cervical cancer screening: Which HPV test to choose?
Adding a high-risk human papillomavirus (HPV) test to cytology may enhance detection of high-grade cervical intraepithelial neoplasia (CIN) in primary cervical cancer screening, with the Cobas 4800 and Hybrid Capture 2 (HC2) tests showing comparable clinical performance in high-risk HPV detection in Chinese women, according to a large study by the University of Hong Kong.
Cervical cancer screening: Which HPV test to choose?
28 Aug 2022
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
Children with Staphylococcus aureus bacteraemia (SAB), a common complication of acute hematogenous osteomyelitis (AHO), are vulnerable to a wide range of illnesses, suggests a study. Thus, classifying its severity may aid in treatment decision-making.